E. Fonseca

644 total citations
15 papers, 23 citations indexed

About

E. Fonseca is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Oncology. According to data from OpenAlex, E. Fonseca has authored 15 papers receiving a total of 23 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Rheumatology and 3 papers in Oncology. Recurrent topics in E. Fonseca's work include Vasculitis and related conditions (6 papers), Otitis Media and Relapsing Polychondritis (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). E. Fonseca is often cited by papers focused on Vasculitis and related conditions (6 papers), Otitis Media and Relapsing Polychondritis (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). E. Fonseca collaborates with scholars based in Spain, United States and Palestinian Territory. E. Fonseca's co-authors include Ricardo Fernández, Jesús Canora, Mercedes Pérez-Conesa, Borja Gracia-Tello, Javier de Castro, María Jesús Castillo, Bartomeu Massutí, Fernando Martínez‐Valle, P. Fanlo and Jaume Mestre-Torres and has published in prestigious journals such as Journal of Clinical Oncology, Annals of the Rheumatic Diseases and European Journal of Cancer.

In The Last Decade

E. Fonseca

13 papers receiving 23 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Fonseca Spain 3 13 9 8 6 6 15 23
G. Couture France 3 12 0.9× 11 1.2× 13 1.6× 3 0.5× 6 1.0× 5 27
S Holawe Austria 4 13 1.0× 14 1.6× 7 0.9× 15 2.5× 3 0.5× 4 43
Clara Leal Portugal 2 7 0.5× 9 1.0× 5 0.6× 4 0.7× 4 0.7× 8 28
Adolfo Rosales Argentina 4 5 0.4× 14 1.6× 4 0.5× 6 1.0× 5 0.8× 9 22
F Sprenger Brazil 4 11 0.8× 7 0.8× 3 0.4× 6 1.0× 5 0.8× 19 32
Isabel Alemany Spain 4 16 1.2× 11 1.2× 12 1.5× 16 2.7× 2 0.3× 6 48
Myriam Jean‐Denis France 4 28 2.2× 13 1.4× 4 0.5× 8 1.3× 3 0.5× 11 42
Miodrag Lazić Serbia 4 21 1.6× 9 1.0× 4 0.5× 15 2.5× 4 0.7× 19 48
Christopher H. Yoo United States 3 18 1.4× 9 1.0× 9 1.1× 7 1.2× 8 33
Anouk Walter‐Petrich France 4 19 1.5× 15 1.7× 3 0.4× 8 1.3× 3 0.5× 13 42

Countries citing papers authored by E. Fonseca

Since Specialization
Citations

This map shows the geographic impact of E. Fonseca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Fonseca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Fonseca more than expected).

Fields of papers citing papers by E. Fonseca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Fonseca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Fonseca. The network helps show where E. Fonseca may publish in the future.

Co-authorship network of co-authors of E. Fonseca

This figure shows the co-authorship network connecting the top 25 collaborators of E. Fonseca. A scholar is included among the top collaborators of E. Fonseca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Fonseca. E. Fonseca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Soláns-Laqué, Roser, E. Fonseca, G. Fraile, et al.. (2025). Identification of risk factors for permanent visual loss in patients with giant cell arteritis. European Journal of Internal Medicine. 139. 106372–106372.
2.
Capdevila, Olga, Francesca Mitjavila, Gerard Espinosa, et al.. (2023). Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients. Medicina. 59(8). 1362–1362. 2 indexed citations
3.
Hernández, Francisco José García, et al.. (2020). FRI0152 PULMONARY HYPERTENSION IN NEWLY DIAGNOSED SPANISH PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM THE RELES COHORT. Annals of the Rheumatic Diseases. 79. 660–660. 1 indexed citations
4.
Fernández‐Codina, Andreu, Blanca Pinilla, Iago Pinal‐Fernandez, et al.. (2019). OP0170 USE OF THE PROVISIONAL EULAR/ACR IGG4-RD CLASSIFICATION CRITERIA IN A COHORT OF SPANISH PATIENTS. Annals of the Rheumatic Diseases. 78. 161–161. 1 indexed citations
5.
Fernández, Roberto J., Felipe X. Cepeda, Á. Sánchez-González, et al.. (2019). PB2182 OUTCOME OF FIRST‐LINE THERAPY FOR PATIENTS WITH SYSTEMIC LIGHT‐CHAIN AMYLOIDOSIS: MONOCENTRIC ANALYSIS. HemaSphere. 3(S1). 979–979. 1 indexed citations
6.
Soláns-Laqué, Roser, et al.. (2019). FRI0265 ANTI-IGE AND ANTI-IL5 THERAPY FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS. Annals of the Rheumatic Diseases. 78. 812–813. 1 indexed citations
7.
Soláns-Laqué, Roser, et al.. (2018). AB0697 Giant cell arteritis with normal inflammatory markers at diagnosis. Annals of the Rheumatic Diseases. 77. 1490–1490.
8.
Rodríguez‐Carballeira, Mónica, G. Fraile, Fernando Martínez‐Valle, et al.. (2016). FRI0362 Pronostic Factors of Survival in ANCA-Associated Vasculitis (AAV). Changes in The New Century. Annals of the Rheumatic Diseases. 75. 566–566. 1 indexed citations
9.
Soláns-Laqué, Roser, G. Fraile, E. Fonseca, et al.. (2016). SAT0365 Risk Factors for Visual Loss in Giant Cell Arteritis (GCA). Annals of the Rheumatic Diseases. 75. 799–799. 1 indexed citations
10.
Soláns-Laqué, Roser, Mónica Rodríguez‐Carballeira, G. Fraile, et al.. (2015). FRI0275 Long-Term Survival and Baseline Prognostic Factors in a Wide Series of Patients with AAV from Spain. Usefulness of Prognostic Scores (Revas Study). Annals of the Rheumatic Diseases. 74. 524–524. 1 indexed citations
11.
Soláns-Laqué, Roser, Luis Caminal‐Montero, Xavier Solanich, et al.. (2012). THU0226 Clinical features and mortality causes in a large cohort of spanish patients with anca associated vasculitides. Annals of the Rheumatic Diseases. 71. 231–232. 1 indexed citations
12.
13.
Fonseca, E., et al.. (2011). Second-line chemotherapy with capecitabine (CAP) and oxaliplatin (OX) in patients with pancreatic or biliary tree adenocarcinoma (ADC).. Journal of Clinical Oncology. 29(4_suppl). 308–308. 8 indexed citations
14.
Martín-Richard, Marta, Vicente Alonso, Daniel Castellano, et al.. (2011). Evaluation of the efficacy and the safety of lanreotide autogel 120 mg on tumor growth stabilization in patients with progressive neuroendocrine tumors (NETs) who are not eligible to surgery or chemotherapy.. Journal of Clinical Oncology. 29(15_suppl). e14660–e14660. 3 indexed citations
15.
Castro, Javier de, Carlos García Girón, E. Fonseca, et al.. (2004). A combination of oxaliplatin and UFT-l,-leucovorin as first line treatment in advanced colorectal cancer. An ONCOPAZ phase II study. Journal of Clinical Oncology. 22(14_suppl). 3726–3726. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Couture Breakdown of academic impact, for papers by S Holawe Breakdown of academic impact, for papers by Clara Leal Breakdown of academic impact, for papers by Adolfo Rosales Breakdown of academic impact, for papers by F Sprenger Breakdown of academic impact, for papers by Isabel Alemany Breakdown of academic impact, for papers by Myriam Jean‐Denis Breakdown of academic impact, for papers by Miodrag Lazić Breakdown of academic impact, for papers by Christopher H. Yoo Breakdown of academic impact, for papers by Anouk Walter‐Petrich
Rankless by CCL
2026